On March 4, By-Health Co.Ltd(300146) ( By-Health Co.Ltd(300146) . SZ) released the annual performance report for 2021. The annual report shows that By-Health Co.Ltd(300146) achieved an operating revenue of 7.431 billion yuan in 2021, an increase of 21.93% over the same period of last year; The net profit attributable to shareholders of listed companies was 1.754 billion yuan, an increase of 15.07% over the same period last year. Red Star capital Bureau noted that in the annual report, Liang Yunchao, chairman of the board of directors, simultaneously issued a letter to shareholders, “build a strong scientific and technological enterprise in eight years”, hoping to preliminarily complete the transformation of a strong scientific and technological enterprise in eight years.
operating income: RMB 7.431 billion
By-Health Co.Ltd(300146) ranking first in market share
The annual report shows that By-Health Co.Ltd(300146) achieved an operating revenue of 7.431 billion yuan in 2021, an increase of 21.93% over the same period of last year; The net profit attributable to shareholders of listed companies was 1.754 billion yuan, an increase of 15.07% over the same period last year; The net profit attributable to shareholders of listed companies after deducting non recurring profits and losses was 1.54 billion yuan, a year-on-year increase of 34.59%. Among them, the main brand ” By-Health Co.Ltd(300146) ” achieved a revenue of 4.445 billion yuan, a year-on-year increase of 24.36%; The revenue of “life space” Chinese products was 184 million yuan, a year-on-year increase of 36.33%.
According to Euromonitor data, the total retail scale of China’s vitamin and dietary supplement (VDS) industry in 2021 was 189.2 billion, with a growth rate of about 6.6% By-Health Co.Ltd(300146) has a market share of 10.3%, ranking first in terms of market share. The second and third market shares were 6.0% and 5.0% respectively. Compared with the previous year, By-Health Co.Ltd(300146) has expanded its leading edge.
In 2021, By-Health Co.Ltd(300146) took frequent actions in the field of new product R & D and marketing. In July, the new product “shubaining” was launched to assist in reducing blood lipids, and the cardiovascular health field was laid out; Release the first personalized customized vitamin concept product to promote the application and transformation of basic research and precision nutrition; In cooperation with Shanghai Institute of nutrition and health, Chinese Academy of Sciences, Mayo Clinic and other global institutions, the anti-aging substance PCC1 was extracted from specific grape seeds, and this breakthrough scientific research achievement on anti-aging was published in the global authoritative scientific magazine Nature metabolism.
In December, By-Health Co.Ltd(300146) became the supplier of sports food and nutrition for Team China national team, providing sports food, nutrition and professional nutrition preparation plan for athletes of more than 70 teams of the national team. Meanwhile, By-Health Co.Ltd(300146) jianlido has become the official supplier of bone health and nutrition products for the 19th Asian Games in Hangzhou in 2022.
want another 8 years
transforming high-tech enterprise
In a letter to shareholders, chairman Liang Yunchao proposed that it would take another eight years to preliminarily complete the transformation of strong scientific and technological enterprises.
By-Health Co.Ltd(300146) hope to launch an original high-tech heavy-duty product developed by ourselves to the market every two or three years in the future; In the future, we can continue to release forward-looking research results such as anti-aging and precision nutrition similar to PCC1 around the world, bringing incremental value to the VDS industry.
It is understood that in the future, By-Health Co.Ltd(300146) will focus on the following three points to realize the transformation of strong scientific and technological enterprises:
I. implement the “scientific nutrition” strategy, continue to build By-Health Co.Ltd(300146) “hard technology” product strength and scientific and technological competitiveness, enable the scientific and technological content of VDS industry and bring incremental value to VDS industry.
II. Continuously strengthen and consolidate the product scientific and technological power of “high-precision and top-notch” functional health food with outstanding competitive advantages of By-Health Co.Ltd(300146) and enlarge the unique advantages of By-Health Co.Ltd(300146) industry.
III. Shanghai Research Center and AI research center of By-Health Co.Ltd(300146) nutrition and Health Research Institute were established in 2022.
Liang Yunchao said that what we do now determines what By-Health Co.Ltd(300146) ‘s future can be. Now, By-Health Co.Ltd(300146) should learn from the benchmarking of global benchmark pharmaceutical enterprises and strive to become one of the VDS enterprises with the strongest scientific and technological power and innovation in the world. “Aim at the moon. Even if you fail, you can at least fall on the clouds.”
